INFECTEX
Infectex is a Russian biotechnology company founded with the goal to develop and bring to the Russian market innovative drugs for the treatment of serious infectious diseases. According to the deliberate strategy of commercialization and international partnerships Infectex plans to form a portfolio of innovative drugs that have high social value and significant market potential. To date the Company develops two pharmaceuticals for tuberculosis.
INFECTEX
Industry:
Biotechnology Pharmaceutical
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.infectex.ru
Status:
Active
Contact:
+7 (495) 726-52-53
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Similar Organizations
Actigenomics
Actigenomics is a biotechnology company.
Official Site Inspections
http://www.infectex.ru Semrush global rank: 6.01 M Semrush visits lastest month: 1.36 K
- Host name: 684641-ct70330.tmweb.ru
- IP address: 188.225.56.75
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "Infectex"
Infectex | Biotechnology company
Infectex, a Russian biotech company in Maxwell Biotech Venture Fund’s portfolio announced today enrollment of the first patients in its Phase IIb-III clinical trial of SQ109 for MDR-TB. …See details»
Инфектекс | Биотехнологическая компания
Компания Инфектекс впервые представила результаты клинического исследования sq 109 на Всероссийской научно-практической конференции фтизиаторовSee details»
About | Infectex
Infectex is a Russian biotechnology company founded with the goal to develop and bring to the Russian market innovative drugs for the treatment of serious infectious diseases. According to …See details»
Infectex - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +7 (495) 726-52-53; Infectex is a Russian biotechnology company founded with the goal to develop and bring to the Russian market …See details»
Infectex Information - RocketReach
Infectex, Ltd is a private biotechnology company founded in 2011 with the goal to develop and bring to the Russian market an innovative drug for the multidrug-resistant tuberculosis (MDR …See details»
Infectex - Overview, News & Competitors | ZoomInfo.com
View Infectex (www.infectex.ru) location in Moscow, Russian Federation , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»
Infectex LLC - Drug pipelines, Patents, Clinical trials - Synapse
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into …See details»
Infectex Company Profile 2024: Valuation, Funding & Investors
Infectex General Information Description. Developer of innovative drugs intended to be sued for the treatment of serious infectious diseases. The company's innovative drugs specialize in …See details»
Infectex, LLC - Biotechnology - Overview, Competitors, and
Infectex, Ltd is a private biotechnology company founded in 2011 with the goal to develop and bring to the Russian market an innovative drug for the multidrug-resistant tuberculosis (MDR …See details»
Компания | Инфектекс - infectex.ru
КОМПАНИЯ «Инфектекс» — частная российская биотехнологическая компания, созданная в 2011 ...See details»
Infectex - Products, Competitors, Financials, Employees, …
Headquarters Location. 7/10 building 3 Bolshaya Polyanka street . Moscow, 119180, Russian Federation. 7 495 411 6992See details»
For immediate release Infectex Announces Positive Phase 2b-3 …
About Infectex Infectex (Moscow, Russia) is a biotechnology company founded in 2011 with the goal to develop and bring to the Russian market drugs for MDR-TB treatment. Currently the …See details»
Infectex - Crunchbase
NeuroMax, GenetX, and Actigenomics focus on genetic research and development, while Infectex specializes in infectious disease research and pharmaceuticals. NeuroMax . Moscow, Moscow …See details»
Team | Инфектекс - infectex.ru
Sergey Borisov SCIENTIFIC ADVISOR. Doctor of Medical Science, Professor of TB at Russian Medical Academy of Postgraduate Education, Deputy Director for science and clinical work at …See details»
Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, …
Jul 26, 2012 SQ109 will be evaluated for efficacy on multi-drug resistant patientsSee details»
Infectex LLC (Infectex LLC) - 药物管线_专利_临床试验_投融营收_最 …
了解Infectex LLC (Infectex LLC)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:感染，技术平台:小分子化药，药物:SQ-109，Telacebec。See details»
Press Release from Infectex and Sequella on SQ-109 clinical trial in ...
Infectex Announces Positive Phase 2b-3 Clinical Trial Results of SQ109 for the Treatment of Multidrug-Resistant Pulmonary Tuberculosis Moscow, Russia and Rockville, MD, USA -- …See details»
Contacts | Infectex
Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs.See details»
Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, …
Jul 26, 2012 SQ109 will be evaluated for efficacy on multi-drug resistant patients Maxwell Biotech Venture Fund's Portfolio Company, Infectex, Receives Russian Regulator's Approval …See details»
Products | Infectex
Tuberculosis causes enormous social and economic damage due to the fact that, in general, it affects the working age population, requires long-term care, medical examination and …See details»